Mod­er­na seeks to dis­miss Al­ny­lam suit over Covid-19 vac­cine com­po­nent, claim­ing wrong venue

RNAi ther­a­peu­tics jug­ger­naut Al­ny­lam Phar­ma­ceu­ti­cals made a splash in March when it sued and sought mon­ey from both Pfiz­er and Mod­er­na re­gard­ing their use of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.